{
    "Trade/Device Name(s)": [
        "RAMP Influenza A/B Assay"
    ],
    "Submitter Information": "Response Biomedical Corporation",
    "510(k) Number": "K093116",
    "Predicate Device Reference 510(k) Number(s)": [
        "K071591"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "GNX"
    ],
    "Summary Letter Date": "September 30, 2009",
    "Summary Letter Received Date": "October 2, 2009",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3330"
    ],
    "Regulation Name(s)": [
        "Influenza Virus Serological Reagents"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Influenza A nucleoprotein antigen",
        "Influenza B nucleoprotein antigen"
    ],
    "Specimen Type(s)": [
        "Nasal wash",
        "Nasal aspirate",
        "Nasopharyngeal aspirate",
        "Nasopharyngeal swab"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "RAMP 200 instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic assay",
        "Fluorescence detection"
    ],
    "Methodologies": [
        "Qualitative immunochromatographic testing"
    ],
    "Submission Type(s)": [
        "Assay",
        "Test",
        "Cartridge"
    ],
    "Document Summary": "FDA 510(k) summary for RAMP Influenza A/B Assay, a qualitative immunochromatographic test for detection of Influenza A and B antigens using the RAMP 200 instrument.",
    "Indications for Use Summary": "Qualitative immunochromatographic assay to identify Influenza A and B nucleoprotein antigens in nasal wash, aspirate, and swab specimens from symptomatic patients to aid rapid differential diagnosis of influenza infection.",
    "fda_folder": "Microbiology"
}